NCT07074548View on ClinicalTrials.gov

The Effect of Hydroxytyrosol in Improving Neutrofil Limfosit Ratio, Monosit Limfosit Ratio, and Super Oxide Dismutase in Pregnant Woman With Hypertension

NANot yet recruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 10, 2025

Primary Completion Date

August 10, 2025

Study Completion Date

August 10, 2025

Conditions
Hypertension in Pregnancy
Interventions
DIETARY_SUPPLEMENT

Placebo

Placebo oral capsule identical in appearance to hydroxytyrosol supplement, administered once daily for 4 weeks.

DIETARY_SUPPLEMENT

Hydroxytyrosol

Hydroxytyrosol is a natural polyphenol with antioxidant and anti-inflammatory properties, derived from olives. In this study, hydroxytyrosol 10 mg will be administered orally once daily for 4 weeks to assess its effects on blood pressure and inflammatory biomarkers in hypertensive pregnant women.

All Listed Sponsors
lead

Dr Cipto Mangunkusumo General Hospital

OTHER

NCT07074548 - The Effect of Hydroxytyrosol in Improving Neutrofil Limfosit Ratio, Monosit Limfosit Ratio, and Super Oxide Dismutase in Pregnant Woman With Hypertension | Biotech Hunter | Biotech Hunter